Bumjin Lim

553 total citations
51 papers, 250 citations indexed

About

Bumjin Lim is a scholar working on Pulmonary and Respiratory Medicine, Surgery and Molecular Biology. According to data from OpenAlex, Bumjin Lim has authored 51 papers receiving a total of 250 indexed citations (citations by other indexed papers that have themselves been cited), including 29 papers in Pulmonary and Respiratory Medicine, 17 papers in Surgery and 10 papers in Molecular Biology. Recurrent topics in Bumjin Lim's work include Prostate Cancer Diagnosis and Treatment (18 papers), Prostate Cancer Treatment and Research (18 papers) and Bladder and Urothelial Cancer Treatments (12 papers). Bumjin Lim is often cited by papers focused on Prostate Cancer Diagnosis and Treatment (18 papers), Prostate Cancer Treatment and Research (18 papers) and Bladder and Urothelial Cancer Treatments (12 papers). Bumjin Lim collaborates with scholars based in South Korea, Malaysia and United States. Bumjin Lim's co-authors include Choung‐Soo Kim, In Gab Jeong, Jun Hyuk Hong, Dalsan You, Myung‐Soo Choo, Miho Song, Yoon Soo Kyung, Bumsik Hong, Hanjong Ahn and Won‐Chul Lee and has published in prestigious journals such as SHILAP Revista de lepidopterología, Scientific Reports and Clinical Cancer Research.

In The Last Decade

Bumjin Lim

42 papers receiving 246 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Bumjin Lim South Korea 11 123 64 51 46 44 51 250
Joseph Mashni United States 9 196 1.6× 98 1.5× 55 1.1× 38 0.8× 12 0.3× 17 309
A. Jurczok Germany 8 85 0.7× 233 3.6× 31 0.6× 35 0.8× 21 0.5× 15 357
Aaron Lay United States 9 252 2.0× 63 1.0× 40 0.8× 48 1.0× 13 0.3× 28 360
Aline C. Tregnago Brazil 10 61 0.5× 187 2.9× 23 0.5× 33 0.7× 20 0.5× 20 294
Abdel‐Rahmène Azzouzi France 8 288 2.3× 87 1.4× 143 2.8× 192 4.2× 27 0.6× 9 401
D. McInerney Ireland 11 57 0.5× 157 2.5× 50 1.0× 24 0.5× 16 0.4× 16 322
Gianpiero Cardone Italy 11 260 2.1× 71 1.1× 61 1.2× 18 0.4× 16 0.4× 28 339
Ahmed Aboumohamed United States 10 151 1.2× 220 3.4× 32 0.6× 113 2.5× 40 0.9× 32 392
Ivan Hoh United Kingdom 8 193 1.6× 45 0.7× 52 1.0× 44 1.0× 19 0.4× 13 287

Countries citing papers authored by Bumjin Lim

Since Specialization
Citations

This map shows the geographic impact of Bumjin Lim's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bumjin Lim with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bumjin Lim more than expected).

Fields of papers citing papers by Bumjin Lim

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bumjin Lim. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bumjin Lim. The network helps show where Bumjin Lim may publish in the future.

Co-authorship network of co-authors of Bumjin Lim

This figure shows the co-authorship network connecting the top 25 collaborators of Bumjin Lim. A scholar is included among the top collaborators of Bumjin Lim based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bumjin Lim. Bumjin Lim is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Lee, Sangmin, et al.. (2025). Diagnostic accuracy of urinary PENK methylation test for urothelial and other cancers: A prospective study. Scientific Reports. 15(1). 22149–22149. 1 indexed citations
3.
Lee, Sangmin, Bumjin Lim, Jung Kwon Kim, et al.. (2024). Incidence and risk factors for dermatologic adverse events following apalutamide use: a real-world data analysis in the Korean population. Prostate International. 13(1). 10–14.
4.
Suh, Jungyo, In Gab Jeong, Bumsik Hong, et al.. (2024). Risk factors for failing to complete gemcitabine–cisplatin neoadjuvant chemotherapy in muscle invasive bladder cancer patients. Investigative and Clinical Urology. 65(3). 256–256.
5.
6.
Suh, Jungyo, Dalsan You, In Gab Jeong, et al.. (2023). Predictive Factors of Abiraterone Response in Patients With High-Risk Metastatic Hormone-Sensitive Prostate Cancer. SHILAP Revista de lepidopterología. 21(3). 257–263.
7.
Suh, Jungyo, Bumjin Lim, Cheryn Song, et al.. (2023). The Predictive Value of the Preoperative Systemic Inflammatory Response Indices in Non–Organ-Confined Disease in Upper Urinary Tract Urothelial Carcinoma. SHILAP Revista de lepidopterología. 21(2). 174–180. 1 indexed citations
8.
Lim, Bumjin, Jungyo Suh, Cheryn Song, et al.. (2023). Efficacy of Partial Nephrectomy in the Management of Unpredicted pT3a Renal Cell Carcinoma. SHILAP Revista de lepidopterología. 21(2). 148–153.
9.
Kim, Dong-Won, Bumjin Lim, Jungyo Suh, et al.. (2023). Clinical Significance of Radical Prostatectomy in Clinical Lymph Node Metastasis in Prostate Cancer. Annals of Surgical Oncology. 30(12). 7903–7909. 1 indexed citations
10.
Suh, Jungyo, et al.. (2022). A Comparative Analysis of Robot-Assisted Laparoscopic Pyeloplasty in Pediatric and Adult Patients: Does Age Matter?. Journal of Clinical Medicine. 11(19). 5651–5651. 1 indexed citations
11.
Kim, Yunlim, Sangjun Yoo, Bumjin Lim, et al.. (2022). A novel biguanide derivative, IM176, induces prostate cancer cell death by modulating the AMPK-mTOR and androgen receptor signaling pathways. Prostate International. 11(2). 83–90. 3 indexed citations
12.
Jeong, In Gab, Bumjin Lim, Sung‐Cheol Yun, et al.. (2021). Adjuvant Low-dose Statin Use after Radical Prostatectomy: The PRO-STAT Randomized Clinical Trial. Clinical Cancer Research. 27(18). 5004–5011. 18 indexed citations
13.
Lim, Bumjin, In Gab Jeong, Cheryn Song, et al.. (2021). Utility of Urinalysis as a Follow-up Surveillance Tool in Nonmuscle Invasive Bladder Cancer. 19(4). 244–251.
14.
Choi, Se Young, Bumjin Lim, Jong Won Lee, et al.. (2021). Construction of a Retrospective Cohort to Observe 10-Year Urologic Cancer Treatment Trends at the Biggest Medical Center of South Korea. 19(4). 232–243. 1 indexed citations
15.
Park, Jun-Young, Jihion Yu, Jun Hyuk Hong, et al.. (2021). Elevated De Ritis Ratio as a Predictor for Acute Kidney Injury after Radical Retropubic Prostatectomy. Journal of Personalized Medicine. 11(9). 836–836. 8 indexed citations
16.
Lim, Bumjin, Won‐Chul Lee, Yoon Soo Kyung, et al.. (2021). Biopsy-detected Gleason grade 5 tumor is an additional prognostic factor in metastatic hormone-sensitive prostate cancer. Journal of Cancer Research and Clinical Oncology. 148(3). 727–734. 5 indexed citations
17.
Park, Kye Jin, et al.. (2020). Comparison of biopsy strategies for prostate biopsy according to lesion size and PSA density in MRI-directed biopsy pathway. Abdominal Radiology. 45(12). 4166–4177. 12 indexed citations
18.
Lee, Sangmin, Bumjin Lim, Dalsan You, et al.. (2020). Association of Bacillus Calmette–Guerin shortages with bladder cancer recurrence: A single-center retrospective study. Urologic Oncology Seminars and Original Investigations. 38(11). 851.e11–851.e17. 11 indexed citations
19.
Lim, Bumjin, Kwang Suk Lee, Juyoung Park, et al.. (2020). External Validation of the Long Short-Term Memory Artificial Neural Network-Based SCaP Survival Calculator for Prediction of Prostate Cancer Survival. Cancer Research and Treatment. 53(2). 558–566. 6 indexed citations
20.
Choi, Se Young, Bumjin Lim, Yoon Soo Kyung, et al.. (2019). Circulating Tumor Cell Counts in Patients With Localized Prostate Cancer Including Those Under Active Surveillance. In Vivo. 33(5). 1615–1620. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Joseph Mashni Breakdown of academic impact, for papers by A. Jurczok Breakdown of academic impact, for papers by Aaron Lay Breakdown of academic impact, for papers by Aline C. Tregnago Breakdown of academic impact, for papers by Abdel‐Rahmène Azzouzi Breakdown of academic impact, for papers by D. McInerney Breakdown of academic impact, for papers by Gianpiero Cardone Breakdown of academic impact, for papers by Ahmed Aboumohamed Breakdown of academic impact, for papers by Ivan Hoh
Rankless by CCL
2026